Table 1.
Patients (n=11 613) | |
---|---|
Age, years | |
Median (IQR) | 5·1 (1·0–14·3) |
Mean (SD) | 7·5 (6·9) |
<2 | 4051 (34·9%) |
2–11 | 3973 (34·2%) |
12–19 | 3589 (30·9%) |
Sex | |
Male | 6032/11 600 (52·0%) |
Female | 5568/11 600 (48·0%) |
Macroregion | |
Southeast | 4065/11 613 (35·0%) |
South | 963/11 613 (8·3%) |
Central-West | 1356/11 613 (11·7%) |
Northeast | 3388/11 613 (29·2%) |
North | 1841/11 613 (15·9%) |
Ethnicity | |
White | 3191/9181 (34·8%) |
Black or Brown | 5784/9181 (63·0%) |
Asian | 79/9181 (0·9%) |
Indigenous | 127/9181 (1·4%) |
Signs and symptoms at presentation | |
Fever | 7604/10 212 (74·5%) |
Cough | 6673/9905 (67·4%) |
Respiratory distress | 5056/9296 (54·4%) |
Oxygen saturation <95% | 3685/8967 (41·1%) |
Dyspnoea | 5527/9601 (57·6%) |
Odynophagia | 2038/8512 (23·9%) |
Anosmia | 336/4601 (7·3%) |
Ageusia | 316/4600 (6·9%) |
Diarrhoea | 1800/8619 (20·9%) |
Vomiting | 1983/8651 (22·9%) |
Abdominal pain | 668/4767 (14·0%) |
Number of comorbidities | |
0 | 8352/11 613 (71·9%) |
1 | 2780/11 613 (23·9%) |
2 | 403/11 613 (3·5%) |
≥3 | 78/11 613 (0·7%) |
Type of comorbidity | |
Asthma | 867/11 613 (7·5%) |
Pulmonary disease | 240/11 613 (2·1%) |
Neurological disorder | 706/11 613 (6·1%) |
Malignancy | 581/11 613 (5·0%) |
Heart disease | 379/11 613 (3·3%) |
Haematological disease | 269/11 613 (2·3%) |
Kidney disease | 173/11 613 (1·5%) |
Diabetes | 210/11 613 (1·8%) |
Obesity | 162/11 613 (1·4%) |
Syndrome or chromosomal aberration | 219/11 613 (1·9%) |
Data are n/N (%) of those with available data. For comorbidities, we assumed missing data to indicate the absence of the given clinical condition.